Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Busulfan and Cyclophosphamide Followed By ALLO BMT

    ... mg/kg 3 times per day (< 40 kg) for up to 30 days unless no engraftment. Other Name: MMF Biological: Allogeneic hematopoietic ...

    Clinical Trial last updated 04/29/2016 - 1:23pm.

  2. Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation

    ... between days +6 and +30. Stop MMF at day +30 or 7 days after engraftment, whichever day is later, if no acute GVHD. Intervention: ...

    Clinical Trial last updated 04/29/2016 - 1:48pm.

  3. Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis.

    ... those with severe fibrosis (n=39) and analyzed regarding engraftment , treatment-related mortality, relapse and survival. RESULTS: ... abnormal cytogenetics . The cumulative incidence of engraftment achieved at day +30 in non-fibrotic patients was 93% and was ...

    Research Article last updated 07/28/2014 - 8:21am.

  4. MDS - Treatment (OLD)

    ... begin to grow and produce blood cells in a process called  engraftment . Until the donated stem cells engraft, you may need blood ...

    Topic section last updated 03/10/2016 - 11:01pm.

  5. Excellent Outcome of Haploidentical Hematopoietic Stem Cell Transplantation in Children and Adolescents with Acquired Severe Aplastic Anemia

    ... Among the 12 patients, 11 achieved neutrophil engraftment at a median of 10 days (range, 9 to 13 days) after HHCT. One patient failed to achieve primary engraftment, and two experienced graft rejection soon after engraftment. All ...

    Research Article last updated 03/05/2013 - 8:11am.

  6. Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia

    ... cord were infused on day 1. Neutrophil engraftment was achieved in all 17 patients in a median time of 16 days (range 9-25 days). The median time of platelet engraftment was 22 days (range 9-95 days) in 16 patients. The cumulative ...

    Research Article last updated 09/04/2014 - 11:22am.

  7. Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia

    ... between donor telomere length and neutrophil engraftment at 28 days (cumulative incidence, 86% vs 85%; HR, 0.94; 95% ...

    Research Article last updated 03/03/2015 - 11:48am.

  8. Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia.

    ... used to reduce graft-versus- host disease (GVHD) and aid engraftment after allogeneic haemopoietic stem cell transplant ... in SAA and show that it results in sustained haematological engraftment, a very low incidence of chronic GVHD without an increase in viral ...

    Research Article last updated 06/20/2013 - 10:30am.

  9. Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia-a single-center experience.

    ... monoclonal antibody was performed. Hematopoietic engraftment , the occurrence of graft-versus-host disease (GVHD) and ... were documented. RESULTS: All patients had rapid engraftment; mean time for neutrophil and platelet recovery was ...

    Research Article last updated 07/09/2013 - 2:48pm.

  10. A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia

    ... to encephalopathy on day 20, achieved neutrophil engraftment a median of 18.5 days after HSCT with complete donor-type ... half-dose CY and FDR is effective for achieving neutrophil engraftment and complete donor-type chimerism. However, subsequent MC may be ...

    Research Article last updated 03/06/2014 - 11:00am.